Reckitt said to have started talks on £6bn sale of homecare assets.


Reckitt Benckiser has reportedly started early discussions with some of the potential suitors for its homecare assets, which could fetch more than £6bn in a deal.

  • Reckitt Benckiser Group
  • 18 September 2024 09:22:55
Reckitt Benckiser Group

Source: Sharecast

Bloomberg cited people familiar with the matter as saying that the consumer goods giant is working with Morgan Stanley for the brands including air freshener Airwick and Cillit Bang cleaners.

Mostly financial investors as well as some consumer companies have shown interest in the assets, the sources said, adding that a formal sale process is likely to kick off within months and be completed in 2025.

It was also understood that Goldman Sachs is helping Reckitt on evaluating options for its formula brand Mead Johnson, including a potential sale. Deliberations are ongoing and no final decision has been made, the people said.

Reckitt announced in July that it was planning to sell some of the homecare brands that it’s deemed non-core and review options for its infant formula business. It said it wanted to focus on "power brands" like Strepsils lozenges, the Mucinex cold remedy, Gaviscon for heartburn and Durex condoms, along with some disinfectants like Harpic, Vanish, Dettol and Lysol that boomed during the pandemic.


Exchange: London Stock Exchange
Sell:
0.00
Buy:
0.00
Change: 0.91 ( 0.01 %)
Date:
Prices delayed by at least 15 minutes

Compare our accounts

If you're looking to grow your money over the longer term (5+ years), we have a range of investment choices to help.

Halifax is not responsible for the content and accuracy of the Markets News articles. We may not share the views of the author. Understand the risks, please remember the value of your investment can go down as well as up and you may not get back the full amount you invest. We don't provide advice so if you are in any doubt about buying and selling shares or making your own investment decisions we recommend you seek advice from a suitably qualified Financial Advisor. Past performance is not a guide to future performance.